文献速递中毒与环境急症消化、代谢与肾脏急症

COVID-19大流行期间美国六家医疗系统急诊科非致死性阿片类药物过量就诊变化

Emergency Department Visits for Nonfatal Opioid Overdose During the COVID-19 Pandemic Across Six US Health Care Systems.
PubMed 文献 · Ann Emerg Med · 2021-03-19
一句话结论2020年COVID-19期间六家医疗系统阿片过量急诊就诊数增10.5%、就诊率增28.5%,尽管全因急诊量降14%,提示需扩大干预。

结果显示2020年阿片过量就诊数较2018、2019年增加10.5%(95%CI 4.18%-17.0%),就诊率从0.25/100次全因急诊升至0.32/100次,增加28.5%(95%CI 23.3%-34.0%),而全因急诊量下降14%。6家医疗系统均出现超过95百分位预测的暴发周,其中2家持续暴发。提示疫情期间阿片相关并发症广泛增加,需扩大社区和医院干预。

要点

  • 2020年阿片过量急诊就诊数3486次,较2018年3020次和2019年3285次增加10.5%(95%CI 4.18%-17.0%)。
  • 阿片过量就诊率从2018-2019年的0.25/100次全因急诊升至2020年的0.32/100次,增加28.5%(95%CI 23.3%-34.0%)。
  • 同期全因急诊就诊量下降14%,但阿片过量就诊数和率均上升,提示阿片相关并发症相对增加。
  • 6家医疗系统均出现超过95百分位预测的暴发周≥6周(偶然预期仅2.6周),其中2家出现持续暴发。
  • 研究结论建议扩大社区和医院干预以支持阿片使用障碍患者并挽救生命。

适用人群与场景

  • 研究对象为非致死性阿片类药物过量急诊就诊;原文未提及排除人群。

诊断标准与关键阈值

  • 阿片过量通过回顾性识别急诊就诊记录确定;原文未提及具体诊断编码或临床标准。
  • 暴发检测采用流行病学暴发检测累积和算法,以超过95百分位预测值判定暴发周;原文未提及其他阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及具体红旗征或需立刻处理的情况。

研究设计与关键结果

  • 回顾性研究,纳入美国6州25家急诊科2018-2020年成人非致死性阿片过量就诊;比较2020年与基于2018-2019年预测的水平。
  • 2020年阿片过量就诊数3486次,较2018年3020次和2019年3285次增加10.5%(95%CI 4.18%-17.0%)。
  • 阿片过量就诊率从2018-2019年的0.25/100次全因急诊升至2020年的0.32/100次,增加28.5%(95%CI 23.3%-34.0%)。
  • 2020年全因急诊就诊量下降14%。
  • 6家医疗系统均出现超过95百分位预测的暴发周≥6周(偶然预期2.6周),其中2家出现持续暴发。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(基于急诊就诊记录)。
  • 局限:回顾性设计;仅纳入6州25家急诊科,可能不具全国代表性;原文未提及其他局限。

对床旁实践的改变

  • 提示COVID-19期间阿片过量急诊就诊数和率增加,尽管全因急诊量下降,急诊和ICU应保持对阿片过量的警惕并扩大社区和医院干预。
  • 原文未提及具体干预措施、适用或不适用人群及常见陷阱。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

STUDY OBJECTIVE: People with opioid use disorder are vulnerable to disruptions in access to addiction treatment and social support during the COVID-19 pandemic. Our study objective was to understand changes in emergency department (ED) utilization following a nonfatal opioid overdose during COVID-19 compared to historical controls in 6 healthcare systems across the United States.

METHODS: Opioid overdoses were retrospectively identified among adult visits to 25 EDs in Alabama, Colorado, Connecticut, North Carolina, Massachusetts, and Rhode Island from January 2018 to December 2020. Overdose visit counts and rates per 100 all-cause ED visits during the COVID-19 pandemic were compared with the levels predicted based on 2018 and 2019 visits using graphical analysis and an epidemiologic outbreak detection cumulative sum algorithm.

RESULTS: Overdose visit counts increased by 10.5% (n=3486; 95% confidence interval [CI] 4.18% to 17.0%) in 2020 compared with the counts in 2018 and 2019 (n=3020 and n=3285, respectively), despite a 14% decline in all-cause ED visits. Opioid overdose rates increased by 28.5% (95% CI 23.3% to 34.0%) from 0.25 per 100 ED visits in 2018 to 2019 to 0.32 per 100 ED visits in 2020. Although all 6 studied health care systems experienced overdose ED visit rates more than the 95th percentile prediction in 6 or more weeks of 2020 (compared with 2.6 weeks as expected by chance), 2 health care systems experienced sustained outbreaks during the COVID-19 pandemic.

CONCLUSION: Despite decreases in ED visits for other medical emergencies, the numbers and rates of opioid overdose-related ED visits in 6 health care systems increased during 2020, suggesting a widespread increase in opioid-related complications during the COVID-19 pandemic. Expanded community- and hospital-based interventions are needed to support people with opioid use disorder and save lives during the COVID-19 pandemic.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Soares WE, Melnick ER, Nath B, et al. Emergency Department Visits for Nonfatal Opioid Overdose During the COVID-19 Pandemic Across Six US Health Care Systems. Ann Emerg Med. 2021. PMID: 34119326. doi:10.1016/j.annemergmed.2021.03.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。